EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interplay between Amiodarone and Statins: Experimental Evidence of Synergistic Hepatotoxicity

Hager Zaki Elghareb, Abdel-Motaal M. Fouda, Mohamed Mahmoud Elhadidi, Ahmed Abdel-Monem Elmetwally

Mansoura Medical Journal · 01.01.2025 · 54 (4)

DOI: 10.58775/2735-3990.1480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mansoura Medical Journal, online erschienen am 01.01.2025. Verfasst von Hager Zaki Elghareb und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug-induced liver injury (DILI) continues to be a main contributor to acute liver failure. So, this study aimed to investigate interactions between amiodarone and atorvastatin concerning hepatic safety, due to increasing clinical practice of their combination for optimal arrhythmia control.

Methods

Forty male Sprague Dawley rats were randomly divided into four groups (10 in each group). Group 1 was control group receiving normal saline. Group 2 received Amiodarone-only \ (administered 30 mg/kg/day orally). Group 3 received Atorvastatin only (administered 10 mg/kg/day orally). Group 4 received combination of both amiodarone and atorvastatin in same previous doses. All drugs were dissolved in saline and administered orally daily for a duration of 8 weeks. At the end of the study, animals were euthanized, and blood and liver tissue samples were obtained for biochemical, histopathological, and molecular analyses.

Results

Treatment of the rats with amiodarone resulted in a significant elevation in liver enzymes than atorvastatin group and controls, signifying hepatocellular damage. Histopathological score signified moderate damage. The combination group showed the most severe liver injury across all groups. Biochemically, liver enzymes levels were dramatically elevated, nearly 5 fold and 3.9-fold higher than control. Oxidative stress reached its peak, reflecting overwhelming lipid peroxidation. In terms of histopathology, this group showed the worst damage: H&E scores reached median of 3 (range 2–3), with extensive necrosis, dense inflammatory infiltrates, severe steatosis, and architectural distortion.

Conclusion

Results showed that the concomitant administration of amiodarone and atorvastatin results in a significantly greater degree of hepatic injury than either drug alone.

Zitieren

APA

Elghareb, H. Z., Fouda, A. M., Elhadidi, M. M., & Elmetwally, A. A. (2025). Interplay between Amiodarone and Statins: Experimental Evidence of Synergistic Hepatotoxicity. Mansoura Medical Journal, 54(4). https://doi.org/10.58775/2735-3990.1480

Vancouver

Elghareb HZ, Fouda AM, Elhadidi MM, Elmetwally AA. Interplay between Amiodarone and Statins: Experimental Evidence of Synergistic Hepatotoxicity. Mansoura Medical Journal. 2025;54(4). doi:10.58775/2735-3990.1480

BibTeX
@article{Elghareb2025,
  author = {Elghareb, Hager Zaki and Fouda, Abdel-Motaal M. and Elhadidi, Mohamed Mahmoud and Elmetwally, Ahmed Abdel-Monem},
  title = {Interplay between Amiodarone and Statins: Experimental Evidence of Synergistic Hepatotoxicity},
  journal = {Mansoura Medical Journal},
  year = {2025},
  volume = {54},
  number = {4},
  doi = {10.58775/2735-3990.1480}
}
Kostenlos starten →